Stocks and Investing Stocks and Investing
Wed, August 10, 2022

Drew Ranieri Maintained (TMCI) at Buy with Increased Target to $23 on, Aug 10th, 2022


Published on 2024-10-27 22:34:37 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Buy with Increased Target from $22 to $23 on, Aug 10th, 2022.

Drew has made no other calls on TMCI in the last 4 months.



There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Drew


  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $21 on, Monday, July 18th, 2022
  • Ryan Zimmerman of "BTIG" Initiated at Strong Buy and Held Target at $22 on, Thursday, May 12th, 2022
Contributing Sources